Novo Nordisk increasingly describes the people who take Wegovy as "customers" rather than "patients," and now labels the drug on its website as a "weight loss" treatment instead of an anti-obesity or weight management medicine, STAT reported. The company has also used slogans such as "Live lighter" and "Summer Glow Up" in advertisements around the world, according to STAT.
The shift arrives nearly eight months after the FDA told Novo that a U.S. television ad for the Wegovy pill was false or misleading. One of the phrases the agency singled out was "live lighter."
